Valiant Laboratories Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹52.46 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.55 per cent from ₹46.20 crore. This corresponds to a year-on-year *(YoY) growth of 48.91 per cent.
Operating Profit
Operating Profit stands at ₹-0.89 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1,212.50 per cent from ₹0.08 crore. This corresponds to a year-on-year *(YoY) decline of 243.55 per cent.
PBDT
PBDT stands at ₹-0.94 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 217.50 per cent from ₹0.80 crore. This corresponds to a year-on-year *(YoY) decline of 143.72 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-2.99 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1,207.41 per cent from ₹0.27 crore. This corresponds to a year-on-year *(YoY) decline of 283.44 per cent.
Net Profit
Net Profit stands at ₹-7.06 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3,630.00 per cent from ₹0.20 crore. This represents a 400.43 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Valiant Laboratories Ltd Earnings
- YOY
- QOQ
Valiant Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Valiant Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Valiant Laboratories Ltd Financial Reports
Valiant Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Valiant Laborato | 3.01% | 5.09% | 7.44% | -8.26% | -29.18% | -31.71% |
| Zim Laboratories | 3.80% | 7.95% | 7.49% | -0.64% | 1.25% | -16.58% |
| Bafna Pharma. | 7.32% | 29.84% | 34.82% | 6.99% | -9.82% | 89.99% |
| Medicamen Biotec | 1.28% | 6.55% | -14.59% | -38.86% | -21.42% | -51.32% |
| Medico Remedies | 1.53% | 1.08% | -6.61% | -17.66% | -23.14% | -34.58% |
| Kerala Ayurveda | 0.85% | 10.70% | 21.26% | -22.23% | -45.09% | -30.19% |
| Astal Lab | 0.74% | 1.30% | -5.29% | -18.20% | -27.11% | -18.35% |
Company Info
Company Information
Chairman & Independent Directo : Mulesh Manilal Savla
ED / MD / Promoter : Santosh S. Vora
ED / WTD / CFO / Promoter : Paresh Shashikant Shah
Non Executive Director : Shantilal Shivji Vora
Non Executive Director : Sandeep Gupta
Independent Non Exe. Director : Sona! A. Vira
Independent Non Exe. Director : Ashok Lakhamshi Chheda
Company Sec. & Compli. Officer : Akshay Gangurde